Member Info for mike33

If want to read something that will chill you to the bone...read this..and note the date published..

Weaponizing Biotech: How China's Military Is Preparing for a 'New Domain of Warfare' - Defense One

https://www.defenseone.com/ideas/2019/08/chinas-military-pursuing-biotech/159167/

DARA chose Kmk to help develop thier next gen. of Bio defence and NATO has given them awards, now they're working on the next generation. financed by UK MOD. It's been said before but the UK lead the world in Genetic sequencing and has the best scientists in the world. Detection of airborne pathogens is all part of this.

Published

12 June 2023

Biological Security Strategy will defend the UK from infectious disease outbreaks, antimicrobial resistance, and biological incidents and attacks

https://www.gov.uk/government/news/dowden-world-class-crisis-capabilities-deployed-to-defeat-biological-threats-of-tomorrow

So Alfonso, sorry Skid what would you like to see exactly happen here? I'm intrigued , you say you've only invested. £5 k here and your many many critical posts here all vague just as the last one...for more than I can remember, would lead one to assume you have a motive...???

Is your dream scenario that the Kmk management throw the towel in next week, and a team of other experts , maybe your mates from your investment house( you did say you worked at a tech invest house) take over, and the share holders are bought out for pennies in the pound..?..

Just as that same management are just striking deals with multi bil dollar global OEMs...you really are insulting the intelligence of everyone here ( maybe rusty nut excluded)

Also while I remember -

when again towards the end of the questions, there was a question about

Board share ownership/ skin in the game etc.

Arnab confirmed all board members have always previously and will this time participate in the funds raise, he also said NO serving board members have ever sold a single share.

I've seen posted on here and elsewhere that Arnab personally has 3 mill+

AQC's fav rant at the mo' over on ADVN

and he inadvertently confirmed that previous serving board members actually held more than the the present ones. although the was trying to make a different point. But that says more that they've held onto their shares I think.

Apols for the spelling errors on the hoof

Well Skid,

all..All...the Chinese stock that you love to mention ...how many times, 30? 40? Is un-delivered and sat in stores, this is on record.

As a man with qualifications (in something) under your belt as you say, are Kromek the only company you're aware of that have had issues dealing with Chinese companies , they are not generally open and straightforward to deal with,

and are more interested in acquiring knowhow and copying tech than being honest customers.

So remind me again why you couldn't be bothered to spend 45 mins if your time to listen to your list of questions that presumably asked after having the phone slammed down on you after demanding email addresses of the boa d of directors....you're stance here is very weird, you think I'm a Kmk employee, don't believe someone who just says Thier an engineer but want me to believe your

Opintons as facts. when you haven't even understood what CZT is, sorry Skid cutting and pasting some lines off made up accounts doesn't cut it with me.

hi bestintown,

alfonso (skid ) has gone a bit shy....it seems.

its interesting that for all the endless moaning talk on here by certain posters who repeat thier opinions as fact and slander the management of kmk daily and weekly, ( i think it's only the cleaners who've escaped his ****ging off) even stating here they would love to have the chance to

ask the management all the pages of searching questions they have, when the chance comes they just sadly can't be bothered. why someone would spend years posting on here and not want to hear directly info from the management baffles me.

this is after they've accused the whole management of being,inept, corrupt, stated that kmk aren't actually even manufacturing the right type of czt? .. absolute nuts, and in the case of the chinese equipment in stock, the fact that china has been in permanent lockdown for the last 2 years was an invention solely created by kmk.

arnab arround the end of the questions mentioned when asked of any updates to the chinese stock sounded positive about it, and said he' d been in hong kong last month and was again back in china next week, so make of that what you will. i read that as there's still a reasonable chance of partial resolution and sale of the kit.

plus asia was mentioned i think as one of the tier 2 customers that they were working with.

someone else might remember the exact wording of the reply better than me.

Oh Skid, there was a question from an Alfonso Skid asking about putting growth before profitability I think.

how many Skids are there out there?

and you missed the update about the Chinese stock then, your favourite moan on here every post all last year and most of the year before.

Someday..he's allergic to the letter 'K'...and..

Some say ...he's never been able to watch his favourite film 'King Kong' all the way thro'
because he comes out in a nasty rash and hot sweats.
Some say... he has an impressive collection of stificates, and qualifications all framed and carefully placed on his bedroom wall, all in Domestic Science.
Some say ...he has beautiful tattoos of emerald green and turquoise blue feathers on both arms and sleeps in a wardrobe on a heavily modified perch and this might be the reason he endlessly repeats himself and pecks at passers-by.
Some say he has an impressive collection of T-Shirts each with the picture of a Sedgefield roundabout on them, his favourite town after many childhood caravan camping holidays there, although he was always told he was going to the seaside, and has never really gotten over this.

But all we know ....he's called the SKID

meanwhile back in the real world of medical CT/CZT sales -
https://www.fiercebiotech.com/medtech/ge-healthcare-revenues-expand-supply-chain-issues-ease

"In its first-quarter earnings report, ultrasound brought in $859 million in revenue, up 5% as the company was able to improve on its backlog as supply chain issues eased. MRI machines, CT scanners and X-ray hardware, meanwhile, raked up $2.5 billion, for an 8% gain. Finally, patient care and monitoring solutions reported a 9% sales increase to $781 million for the quarter."

Looking back over old articles and broker reports on the number of OEMs that KROMEK have said they’ve been engaged with,
It’s been steadily rising from 11 OEMs in July 2018 (IC article) to 15? odd now as mentioned by Finncap recently.
Along with the CZT furnace capacity increasing by 5 fold UK & US Pittsburgh? to x154 using funds from the last fund raise, they are well
placed to ramp up production for these new contracts and delivery agreements just announced, and any news ones to come.
the other OEMs which are expected to sign formal contracts have been
working with Kromek for a similar considerable number of years as well by the look of it. so likely in advanced prototype testing and validation
phases and planning to launch CZT based scanners in the near future , so more OEM contract news coming soon hopefully.
From the last paragraph of the Finncap report it was stated...
''The validation and endorsement that this agreement (first tier 1 customer signing) brings is expected to drive the remaining OEMs to source CZT from Kromek.
This group of OEMs accounts for est 10-15% of the current market, which represents a current end-user CT CZT market value of the region $0.8-1.0bn.
We expect Kromek to win additional customers looking for CZT detection solutions in both SPECT and CT.
Tier 2 CT OEMs accounted for an estimated 12% share of the CT market in 2022''
So who's left -
Philips Medical Systems (last tier 1) - been mentioned many times but yet to sign on the dotted line
So the remaining tier 2 CT CZT medical imaging companies that Kromek are engaged with are -
UNITED IMAGING - regularly mentioned
NEUROLOGICA - subsidiary of Samsung
FUJI - Medical Systems
MARS Bio-imaging - metabolic and functional imaging for drug development studies
Mediso - of Budapest
Toshiba - Japan
Hitachi - were engaged with Redlen (Canon now) - 2016?
GMI+ can't find anything on them..
++++ a couple of others unknowns by the sound of it.
Every OEM Medical Imaging contract bagged will very likely be a long production runs, with good earnings visibility.
I can’t see the share price staying at this level for long when the penny drops.

given that Kromek signed a $58.1m 7-year supply agreement in 2019 with a Tier 2 OEM now just announced as Spectrum Dynamics,

(i previously thought it was with Philips)

It’s probably safe to say that the Bath's RUH Hospital's recent purchase of a new Spectrum Dynamics VERITON CT scanner uses Kromeks CZT modules.

this being the first of its kind to be installed anywhere in the UK.



https://spectrum-dynamics.com/royal-united-hospitals-bath-nhs-foundation-trust-united-kingdom/

Impressive company -
https://www.analogic.com/wp-content/uploads/2021/05/Analogic-Compressed-1.mp4

kromeks -tier 1 customer -
its either Siemens or Philips, each a world leading medical imaging company and a fantastic endorsement for KMKs engineering.
The CT global market was worth est. -$6.7bn in 2022 and is forecast to grow to Approx.. $10bn by 2030. Assuming CZT modules represent approx.. 20% by value of a CZT-based CT scanner,
it implies a potential es.t -$2bn CZT market in 2030. We estimate the four existing Tier 1 OEMs in the CT imaging market to

share approx.. 85-90% of this market. (Based on the CZT component modules being approx.. 15-20% CT market share), it would imply an
es.t-$300-400m potential addressable market from this 'just announced' KMK Tier 1 OEM contract alone.
It’s believed that this Tier 1 OEM will have entered this long-term agreement satisfied that Kromek’s technical capabilities,
quality systems and IP are robust and that its production facilities are capable of scaling to meet the customer’s expected demand.
After long periods of scoping and spec engineering team work.
Siemens whilst not named for commercial reasons could be the tier 1 customer, given that its (own in house) cadmium-telluride detectors are not deemed to be suitable for SPECT imaging.
In 2010, Siemens acquired Acorad (Japan) to enable it to develop a cadmium telluride-based CT system.

In 2021, Siemens launched the world's first photon-counting computed tomography (PCCT) scanner,
Naeotom Alpha, illustrating the time and investment commitment by a global imaging company to develop this market.
The other only remaining Tier 1 OEM is Philips Medical Systems, which would be expected to participate in this transition, or run the risk of losing its market share to the next-generation of advanced CT scanners.
Philips has no known in-house CZT manufacturing capabilities.
Canon and GE both have acquired their own CZT manufactures, at considerable cost.

Well Ark, this is a general comment here, ie not just at you're good self, but I don't bother to post on any another of all the companies I follow. I don't because every other one I follow mostly tech innovative, disruptive call them want you want all have full on very informed savvy (who can even spell) posters, they are all over the companies (SRT, Nano,+) here that's not the case for some reason, all the serial moaners on here one single quality..they never do any research..never post any links never look at the future potential here..just bang on about the past...why this is just on this board I can't fathom, I'm just an engineer who knows how long it takes to get things thro' testing and approvals, etc but there's posters on here that endlessly post negative posts who are hairdressers, some even say they have stif-icates . Just remember empty vessel's make more noise.

Well GE only launched the first ever CZT in 2017, and there was no market for CZT then, it's been a slow train coming, Kromek weren't a company many would have considered a investment then, just wearable + static radiation detectors, I'm talking about recent history...last few years..then trains now arrived at platform 1

What’s struck me this week with the latest flurry of Kromek agreements announced with OEMs securing their CZT module designs and ensured CZT future supply, and the all revealing Finncap write up detailing clearly the unique position Kromek finds itself in.
is how this has all been foretold and predicted by Kromeks management.
They've watched for years the medical imaging OEMs adoption of CZT by GE initially then Philips, Spectrum Dynamics, and even Siemens who have in house Acrorad of Japan (but it seems un-suitable CZT Spect grade supply) and the moves to buy out the very few companies who make it.
It’s been a concern for some that Kromek would be split up and taken out at a discount of its true worth and potential with
patient shareholders not seeing the benefit from the years of R&D hard work and investments put in.
Many here relentlessly criticize the management and its business plans to date, when it looks to me they've quietly played a very shrude policy of not falling into bed with one OEM or another, probably resisting offers of 10, 15 % stake company investments
(as Cannon with REDLEN) from large OEMs that would shackle them and limit their ability to offer any truly independent supply to other companies. What’s happened this week is the confirmation i hope/believe that Kromek will remain an independent CZT supplier to many
global customers for years to come and go on to be a sizeable and respected and very profitable company.
one for the pension pot.

Imaging and Detection - Analogic

https://www.analogic.com/imaging-and-detection/?locale=en

19 April 2023
Kromek Group plc
Kromek and Analogic Announce Collaboration Agreement to Develop Next Generation
Computed Tomography (CT) Detector Technology

CZT-based Photon Counting CT technology is poised to enable imaging and detection breakthroughs
not achievable with conventional technology
Kromek Group plc (AIM: KMK) and Analogic Corporation today announced they have entered into an agreement to collaborate on the development of next-generation Cadmium Zinc Telluride (CZT) based detector solutions for Photon Counting Computed Tomography (PCCT) applications in the medical imaging and security sectors.